Earnings Releases

CREDIT ACCEPTANCE CORP reported three months ended March 31, 2026 results: net income Adjusted net income . . . was $117.3 million, EPS $10.71 per diluted share.

“million, or $12.40 per diluted share, for the three months ended March 31, 2026. Adjusted net income, a non-GAAP financial measure, for the three months ended March 31, 2026 was $117.3 million, or $10.71 per diluted share. The following table summarizes our financial results: (In millions, except per share data) For the Three Months Ended March 31, 2026 December 31,”

KADANT INC reported the first quarter ended April 4, 2026 results: revenue $282 million, net income $26 million, EPS $2.16.

“its financial results for the first quarter ended April 4, 2026. First Quarter Financial Highlights • Bookings increased 25% to a record $321 million • Revenue increased 18% to $282 million • Gross margin decreased 110 basis points to 45.0% • Net income increased 6% to $26 million • GAAP EPS increased 6% to $2.16 • Adjusted EPS increased 14% to $2.84 • Adjusted”

CONSUMER PORTFOLIO SERVICES, INC. reported first quarter ended March 31, 2026 results: revenue $112.3 million, net income $5.5 million, EPS $0.24 per diluted share.

“passcode 8293043. --- EX-99.1 (PRESS RELEASE) --- EX-99.1 2 cps_ex9901.htm PRESS RELEASE Exhibit 99.1 NEWS RELEASE CPS ANNOUNCES FIRST QUARTER 2026 EARNINGS § Revenues of $112.3 million compared to $106.9 million in the prior year period § Net income of $5.5 million for the first quarter of 2026, an 18% increase from prior year § Total portfolio balance of”

Match Group, Inc. reported Q2 2026 results: revenue $850 to $860 million.

“For Q2 2026, Match Group expects: • Total Revenue of $850 to $860 million, down 2% to flat Y/Y. • Adjusted EBITDA of $325 to $330 million, representing a Y/Y increase of 13% at the midpoints of the ranges. • Adjusted EBITDA Margin of 38% at the midpoints of the ranges.”

Match Group, Inc. reported first quarter ended March 31, 2026 results: revenue $864 million, net income $167 million.

“Total Revenue of $864 million was up 4% year-over-year (“Y/Y”), flat on a foreign exchange (“FX”) neutral basis (“FXN”), driven by a 10% Y/Y increase in RPP to $20.90 , partially offset by a 5% Y/Y decline in Payers to 13.5 million . • Net Income of $167 million increased 42% Y/Y, representing a Net Income Margin of 19% .”

Pediatrix Medical Group, Inc. reported three months ended March 31, 2026 results: revenue $476 million, net income $30 million, EPS $0.36 per share. Guidance reaffirmed.

“ended March 31, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44. For the 2026 first quarter, Pediatrix reported the following results: • Net revenue of $476 million; • Net income of $30 million; and • Adjusted EBITDA of $58 million. “Our first quarter operating results exceeded our expectations, driven by top-line growth,” said Mark S.”

Theriva Biologics, Inc. reported financial results for quarter ended March 31, 2026.

“On May 5, 2026, Theriva Biologics, Inc., a Nevada corporation (the “Company”), issued a press release that included financial information for its quarter ended March 31, 2026.”

WOLFSPEED, INC. reported third quarter of fiscal 2026 results: revenue approximately $150 million, net income GAAP net loss of $120 million.

“potential of the site. • CFIUS clearance and equity issuance to Renesas completes Chapter 11 procedures. Quarterly Financial Highlights • Consolidated revenue of approximately $150 million, aligned with midpoint of guidance range. • GAAP gross margin of (27)% and Non-GAAP gross margin of (21)%. • GAAP net loss of $120 million and adjusted EBITDA of ($62) million. •”

USANA HEALTH SCIENCES INC reported first quarter ended April 4, 2026 results: revenue $250 million, net income $7.5 million, EPS $0.41. Guidance reaffirmed.

“(NYSE: USNA) today announced financial results for its fiscal first quarter ended April 4, 2026. Key Financial Results First Quarter 2026 vs. First Quarter 2025 • Net sales of $250 million versus $250 million. • Net earnings of $7.5 million versus $9.4 million. • Diluted EPS of $0.41 as compared with $0.49. • Adjusted diluted EPS (1) of $0.61 as compared with”

MYRIAD GENETICS INC reported first quarter ended March 31, 2026 results: revenue 200.4 million, net income net loss of $34.1 million, EPS loss per share was $0.09 per share. Guidance reaffirmed.

“First quarter 2026 revenue of $200.4 million grew 2% year-over-year, reflecting stable test volume and 2% year-over-year growth in average revenue per test.”

NEUROCRINE BIOSCIENCES INC reported first quarter ended March 31, 2026 results: revenue 814.5 million dollars, net income 197.9 million dollars, EPS 1.91 dollars per share. Guidance reaffirmed.

“Neurocrine Biosciences Reports First-Quarter 2026 Financial Results Total First-Quarter 2026 Net Product Sales of $811.0 Million, An Increase of 44% Year-Over-Year Announced Definitive Agreement to Acquire Soleno Therapeutics, Including VYKAT TM XR (diazoxide choline) for the Treatment of Hyperphagia in Prader-Willi Syndrome Expected to Close in Q2 2026 Initiated Phase 2 Clinical Study of NBI-1117570, a Dual M1 / M4 Selective Agonist, in Adults with Schizophrenia Reaffirmed 2026 Full-Year INGREZZA ® (valbenazine) Net Sales Guidance of $2.7 - $2.8 Billion SAN DIEGO , May 5, 2026 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2026.”

INTEGRA LIFESCIENCES HOLDINGS CORP reported the first quarter ending March 31, 2026 results: revenue $391.9 million, net income $(4.6) million, EPS $(0.06) per diluted share. Guidance raised.

“Total reported revenues of $391.9 million increased 2.4% on a reported basis and 1.3% on an organic basis compared to the prior year. The Company reported GAAP gross margin of 55.4%, compared to 50.8% in the first quarter of 2025. Adjusted gross margin was 64.1%, compared to 62.2% in the prior year. Adjusted EBITDA for the first quarter of 2026 was $76.2 million, or 19.4% of revenue, compared to $63.6 million, or 16.6% of revenue, in the prior year. The Company reported a GAAP net loss of $(4.6) million, or $(0.06) per diluted share, in the first quarter of 2026, compared to GAAP net loss of $(25.3) million, or $(0.33) per diluted share, in the prior year.”

SSR MINING INC. reported first quarter ended March 31, 2026 results: revenue $581,778, net income $252,476, EPS $1.16 per diluted share. Guidance reaffirmed.

“31, 2026 and March 31, 2025 are presented below: (in thousands, except per share data or otherwise stated) Three Months Ended March 31, 2026 2025 Financial Results Revenue $ 581,778 $ 316,618 Cost of sales $ 195,119 $ 136,641 Operating income $ 300,381 $ 106,784 Net income (loss) $ (115,152) $ 54,446 Net income from continuing operations $ 250,181 $ 89,174”

ADTRAN Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $286.1 million, EPS GAAP diluted loss per share of $0.01; non-GAAP diluted earnings per share of $0.14. Guidance initiated.

“(NASDAQ: ADTN and FSE: QH9) (“ADTRAN Holdings” “ADTRAN” or the “Company”) today announced its unaudited financial results for the first quarter ended March 31, 2026. • Revenue: $286.1 million, up 15.5% year-over-year. • GAAP gross margin of 39.5%; Non-GAAP gross margin of 43.0%; up 108 and 55 basis points year-over-year, respectively. • Operating margin: GAAP”

DAVITA INC. reported the quarter ended March 31, 2026 results: revenue $3.416 billion, net income $198 million, EPS $2.87.

“strong financial performance, and this quarter is no exception.” Financial and operating highlights for the quarter and year ended March 31, 2026: • Consolidated revenues were $3.416 billion. • Operating income was $482 million. • Diluted earnings per share from continuing operations was $2.87. • Operating cash flow was $321 million and free cash flow was $140”

FLOTEK INDUSTRIES INC/CN/ reported the quarter ended March 31, 2026 results: revenue $70,051, net income $4,664, EPS $0.12 per diluted share. Guidance initiated.

“financial metrics compared to the prior-year quarter is as follows ( in thousands, except ‘per share’ amounts ): Three Months Ended March 31, 2026 2025 % Change Total Revenues $ 70,051 $ 55,362 27% Gross Profit $ 15,541 $ 12,449 25% Net Income $ 4,664 $ 5,380 (13)% Diluted Income Per Share $ 0.12 $ 0.17 (29)% Adjusted EBITDA (1) $ 9,093 $ 6,298 44% First Quarter”

Azenta, Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $145 million, EPS ($3.41). Guidance lowered.

“position Azenta for improved execution, greater consistency, and profitable long‐term value creation.” Second Quarter Fiscal 2026 Results - Continuing Operations • Revenue was $145 million, up 1% year over year. Organic revenue, which excludes a 3-percentage point impact from foreign exchange and a 1-percentage point from the acquisition of UK Biocentre Limited,”

BALL Corp reported first quarter ended March 31, 2026 results: revenue $3.60 billion, net income $205 million, EPS 77 cents. Guidance reaffirmed.

“On a U.S. GAAP basis, the company reported first quarter 2026 net earnings attributable to the corporation of $205 million or total diluted earnings per share of 77 cents, on sales of $3.60 billion”

EXELIXIS, INC. reported first quarter of 2026 results: revenue $610.8 million, net income $210.5 million, EPS $0.79 per share, diluted.

“& Investor Relations Exelixis, Inc. 650-837-7248 apeters@exelixis.com Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update - Total Revenues of $610.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $555.0 million - - GAAP Diluted EPS of $0.79, Non-GAAP Diluted EPS of $0.87 - - Announced Additional Stock Repurchase Program”

SOCKET MOBILE, INC. reported the three months ended March 31, 2026 results: revenue $3.7 million, net income operating loss of $0.8 million.

“with generally accepted accounting principles in the United States ("GAAP") for the three months ended March 31, 2026. First Quarter 2026 Financial Highlights: • Revenue of $3.7 million, a 7% decrease from $4.0 million in both the prior-year quarter and Q4 2025. • Gross margin of 51.3% compared with 50.4% in the prior-year quarter and 50.2% in the preceding”

GLOBAL INDUSTRIAL Co reported first quarter ended March 31, 2026 results: revenue $350.4 million, net income $15.3 million, EPS $0.39.

“financial results for the first quarter ended March 31, 2026. --- EX-99.1 (EX-99.1) --- GLOBAL INDUSTRIAL REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS Sales Increased 9.2% to $350.4 Million Operating Income Improved 13.2% to $20.6 Million; Operating Margin 5.9% Board Declared $0.28 Dividend PORT WASHINGTON, NY, May 5, 2026 – Global Industrial Company (NYSE: GIC) , a”

TEREX CORP reported financial results for first quarter 2026.

“Attached as Exhibit 99.1 to this Form 8-K of Terex Corporation (“Terex”) are the prepared statements of Terex from its May 1, 2026, conference call providing certain first quarter financial results.”

TACTILE SYSTEMS TECHNOLOGY INC reported the first quarter ended March 31, 2026 results: revenue $75.3 million, net income $1.8 million, EPS $0.08 per diluted share. Guidance raised.

“Total revenue in the first quarter of 2026 increased $14.0 million, or 23%, to $75.3 million, compared to $61.3 million in the first quarter of 2025. The increase in total revenue was attributable to an increase of $11.7 million, or 23%, in sales and rentals of the lymphedema product line and an increase of $2.3 million, or 22%, in sales of the airway clearance product line. Gross profit in the first quarter of 2026 increased $12.3 million, or 27%, to $57.6 million, compared to $45.3 million in the first quarter of 2025. Gross margin was 76.5% of revenue, compared to 74% of revenue in the first quarter of 2025. Operating expenses in the first quarter of 2026 increased $9.3 million, or 19%, to $59.1 million, compared to $49.9 million in the first quarter of 2025. Operating loss was $1.5 million in the first quarter of 2026, compared to $4.5 million in the first quarter of 2025. Income tax expense was $0.9 million in the first quarter of 2026, compared to an income tax benefit of $1.1 mi”

OSI SYSTEMS INC reported third quarter of fiscal 2026 results: revenue $453,246, EPS $2.33. Guidance reaffirmed.

“Summary Three Months Ended March 31, Nine Months Ended March 31, (Dollars in thousands, except per-share amounts) 2025 2026 % Growth 2025 2026 % Growth Revenues $ 444,354 $ 453,246 2 % $ 1,208,181 1,301,926 8 % Diluted earnings per share - GAAP $ 2.40 $ 2.33 -3 % $ 5.67 $ 5.71 1 % Diluted earnings per share - non-GAAP $ 2.44 $ 2.60 7 % $ 6.11 $ 6.60 8 % Cash”

VORNADO REALTY LP reported first quarter of 2026 results: net income $22,842,000, or $0.12 per diluted share.

“NET LOSS attributable to common shareholders for the quarter ended March 31, 2026 was $22,842,000, or $0.12 per diluted share, compared to net income attributable to common shareholders of $86,842,000, or $0.43 per diluted share, for the prior year's quarter.”

Innovex International, Inc. reported the quarter ended March 31, 2026 results: revenue $239 million, net income Net Loss of $17 million.

“Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the first quarter of 2026. First Quarter Highlights • Revenue of $239 million, down 13% quarter-over-quarter and down 1% year-over-year • Net Loss of $17 million and Net Loss Margin of (7)% • Adjusted EBITDA 1 of $49 million and Adjusted EBITDA Margin 1 of”

RB GLOBAL INC. updated its full-year 2026 guidance (raised).

“The Company has updated its full-year 2026 outlook for select financial data, as shown below:”

RB GLOBAL INC. reported the three months ended March 31, 2026 results: revenue $1.2 billion, net income $135.6 million, EPS $0.66 per share.

“First Quarter Financial Highlights 1,2,3 : • Total gross transaction value ("GTV") increased 13% year over year to $4.3 billion. • Total revenue increased 11% year over year to $1.2 billion. • Service revenue increased 5% year over year to $897.7 million. • Inventory sales revenue increased 32% year over year to $336.9 million. • Net income increased 20% year over”

BIOMARIN PHARMACEUTICAL INC reported the first quarter ended March 31, 2026 results: revenue $766 million, net income $106 million. Guidance raised.

“Total Revenues for the first quarter of 2026 were $766 million”

WILLIAMS COMPANIES, INC. reported the three months ended March 31, 2026 results: net income $864 million, or $0.70 per diluted share (EPS), EPS $0.70 per diluted share. Guidance reaffirmed.

“announced its unaudited financial results for the three months ended March 31, 2026. Natural gas-focused strategy continues to drive key financial results • GAAP net income: $864 million, or $0.70 per diluted share (EPS), up 25% vs. 1Q 2025 • Adjusted net income: $895 million, or $0.73 per diluted share (Adj. EPS), up 23% and 22%, respectively, vs. 1Q 2025 •”

DIVERSIFIED HEALTHCARE TRUST reported financial results for the quarter ended March 31, 2026.

“On May 4, 2026 , Diversified Healthcare Trust, or the Company, issued a summary press release and a detailed earnings presentation announcing the Company's financial results for the quarter ended March 31, 2026.”

GAIA, INC reported first quarter ended March 31, 2026 results: revenue $24.3 million, net income $(1.3) million, EPS $(0.05) per share.

“company, reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary vs First Quarter 2025 (where applicable) • Revenue increased to $24.3 million compared to $23.8 million. • Gross profit remained flat at $20.9 million. • Generated $1.5 million in operating cash flow and $1.1 million in free cash flow. Management”

HEALTHSTREAM INC updated its full year 2026 guidance (reaffirmed).

“The Company reaffirms its guidance for 2026 for the measures set forth below as previously announced on February 23, 2026.”

HEALTHSTREAM INC reported first quarter ended March 31, 2026 results: revenue $81.2 million, net income $5.9 million, EPS $0.20 per share (diluted). Guidance reaffirmed.

“healthcare technology platform company for clinical workforce solutions, today announced results for the first quarter ended March 31, 2026 . First Quarter 2026 • Revenues of $81.2 million, up 10.5% from $73.5 million in the first quarter of 2025 , setting a new Company record for quarterly revenue • Operating income of $7.5 million, up 71.6% from $4.4 million in”

Cryoport, Inc. reported first quarter (Q1) of 2026 results: revenue $47.8 million. Guidance raised.

“99.1) --- EX-99.1 2 tm2613494d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cryoport Reports First Quarter 2026 Financial Results ● First quarter revenue grew 16% year-over-year to $47.8 million ● Commercial cell and gene therapy (CGT) revenue grew 26% year-over-year to $9.1 million, reflecting continued expansion in approved CGT programs ● Life Sciences Services”

COGENT COMMUNICATIONS HOLDINGS, INC. reported the first quarter of 2026 results: revenue $239.2 million, EPS $(0.83).

“Cogent Communications Holdings, Inc. (NASDAQ: CCOI) (“Cogent”) today announced service revenue of $239.2 million for the three months ended March 31, 2026, a decrease of 0.6% from the three months ended December 31, 2025 and a decrease of 3.2% from the three months ended March 31, 2025. Foreign exchange rates positively impacted service revenue growth from the three months ended December 31, 2025 to the three months ended March 31, 2026 by $0.3 million and positively impacted service revenue growth from the three months ended March 31, 2025 to the three months ended March 31, 2026 by $3.4 million. On a constant currency basis, service revenue decreased by 0.7% from the three months ended December 31, 2025 to the three months ended March 31, 2026 and decreased by 4.6% from the three months ended March 31, 2025 to the three months ended March 31, 2026. Page 1 of 19 On-net service is provided to customers located in buildings that are physically connected to Cogent’s network by Cogent fac”

Sonos Inc reported financial results for Second Quarter Fiscal 2026.

“On May 4, 2026, Sonos, Inc. (the “Company”) issued a press release announcing its financial results for its second fiscal quarter ended March 28, 2026.”

NCL CORP Ltd. reported first quarter ended March 31, 2026 results: revenue $2.3 billion, net income $104.7 million, EPS $0.23. Guidance lowered.

“financial results for the first quarter ended March 31, 2026 and provided guidance for the second quarter and full year 2026. Highlights First quarter total revenue grew 10% to $2.3 billion. GAAP net income was $105 million, with EPS of $0.23. Delivered Adjusted EBITDA 1 of $533 million in first quarter 2026, exceeding guidance, and representing an increase of 18%”

FreightCar America, Inc. reported the first quarter ended March 31, 2026 results: revenue $64.3 million, net income $41.6 million, EPS $1.15 per share. Guidance reaffirmed.

“supplier of railroad freight cars, railcar parts and components, today reported results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights • Revenues of $64.3 million, consistent with expectations, compared to $96.3 million in the first quarter of 2025, with railcar deliveries of 577 units compared to 710 units in the prior year period • Gross”

Palantir Technologies Inc. reported the first quarter ended March 31, 2026 results: revenue $1.633 billion, net income $871 million, EPS $0.34. Guidance raised.

“to $595 million ◦ U.S. government revenue grew 84% year-over-year and 21% quarter-over-quarter to $687 million • Revenue grew 85% year-over-year and 16% quarter-over-quarter to $1.633 billion • Closed 206 deals of at least $1 million, 72 deals of at least $5 million, and 47 deals of at least $10 million • Closed total contract value (“TCV”) of $2.41 billion, up 61%”

BOISE CASCADE Co reported first quarter ended March 31, 2026 results: revenue $1.5 billion, net income $17.8 million, EPS $0.50 per share.

“Boise Cascade Company ("Boise Cascade," the "Company," "we," or "our") (NYSE: BCC) today reported net income of $17.8 million, or $0.50 per share, on sales of $1.5 billion for the first quarter ended March 31, 2026, compared with net income of $40.3 million, or $1.06 per share, on sales of $1.5 billion for the first quarter ended March 31, 2025.”

Equitable Holdings, Inc. reported the quarter ended March 31, 2026 results: net income $621 million, EPS $2.14 per share.

“specific reference in such a filing. --- EX-99.1 (EX-99.1) --- EQUITABLE HOLDINGS REPORTS FIRST QUARTER 2026 RESULTS _______________________________________ • Net income of $621 million, or $2.14 per share • Non-GAAP operating earnings 1 of $472 million, or $1.62 per share; Adjusting for notable items 2 , Non-GAAP operating earnings of $491 million, or $1.68 per”

AVIAT NETWORKS, INC. reported the third quarter ended March 27, 2026 results: revenue $100.0 million, net income $2.1 million, EPS $0.16.

“in Exhibit 99.1 of this report. --- EX-99.1 (EX-99.1) --- Aviat Networks Announces Fiscal 2026 Third Quarter and Nine Month Financial Results Total Q3 QTD Revenues of $100.0 million Q3 QTD Operating Income of $0.9 million; Q3 QTD Non-GAAP Operating Income of $3.0 million Q3 QTD Net Earnings of $(2.1) million; Q3 QTD Adjusted EBITDA of $4.4 million Q3 QTD”

Fabrinet reported third fiscal quarter ended March 27, 2026 results: revenue $1,214.3 million, net income $125.2 million, EPS $3.45. Guidance reaffirmed.

“as we move into the fourth quarter and beyond.” Third Quarter Fiscal Year 2026 Fi nancial Highlights GAAP Results • Revenue for the third quarter of fiscal year 2026 was $1,214.3 million, compared to $871.8 million for the third quarter of fiscal year 2025. • GAAP net income for the third quarter of fiscal year 2026 was $125.2 million, compared to $81.3 million”

Allison Transmission Holdings Inc reported for the three months ended March 31, 2026 results: revenue $1,406 million, net income $112 million, EPS Diluted EPS of $1.33, Adjusted Diluted EPS of $2.57.

“set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 News Release Allison Announces First Quarter 2026 Results * Net Sales of $1,406 million, up 84% year over year, including the addition of the Allison Off-Highway business unit acquired on January 1, 2026 * Net Income of $112 million, 8% of Net Sales * Diluted EPS of”

Apple Hospitality REIT, Inc. reported the first quarter ended March 31, 2026 results: net income $27,699, EPS $0.12.

“As of and For the Three Months Ended March 31 (Unaudited) (in thousands, except statistical and per share amounts) (1) Three Months Ended March 31, 2026 2025 % Change Net income $27,699 $31,221 (11.3%) Net income per share $0.12 $0.13 (7.7%) Operating income $48,013 $50,859 (5.6%) Operating margin % 14.2% 15.5% (130 bps) Adjusted EBITDAre $100,597 $98,446 2.2%”

InspireMD, Inc. reported first quarter ended March 31, 2026 results: revenue $3.4 million, net income $13.7 million, EPS $0.16 per basic and diluted share.

“expressly set forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- InspireMD Reports First Quarter 2026 Financial Results - Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard neuro protection system for use in”

JBT MAREL Corp reported full year 2026 results: revenue $3,990 - $4,065, EPS $4.70 - $5.15. Guidance reaffirmed.

“JBT Marel is reiterating its full year 2026 guidance, and the below table reflects consolidated guidance. Guidance In millions except EPS and margin FY 2026 Revenue $3,990 - $4,065 Net income margin 6.1% - 6.6% Adjusted EBITDA margin (1) 17.0% - 17.5% GAAP diluted EPS $4.70 - $5.15 Adjusted EPS (1) $8.00 - $8.50”

JBT MAREL Corp reported first quarter ended March 31, 2026 results: revenue $936 million, net income $45 million, EPS $0.86.

“First quarter 2026 consolidated revenue of $936 million increased 10 percent with approximately 6 percent benefit from foreign exchange translation. The foreign exchange benefit was largely as expected. Net income of $45 million improved $218 million, and net income margin was 4.8 percent. The improvement in net income was primarily driven by lower non-recurring and transaction related costs as well as margin enhancement efforts and lower interest expense. First quarter 2026 consolidated adjusted EBITDA of $142 million improved $30 million, and adjusted EBITDA margin was 15.2 percent. Diluted earnings per share (EPS) was $0.86 compared to a loss per share of $3.35. Adjusted EPS was $1.58 compared to $0.97.”

Travere Therapeutics, Inc. reported the quarter ended March 31, 2026 results: revenue $124.5 million, net income Net loss for the first quarter of 2026 was $37.1 million, or $0.40 per basic share, EPS $0.40 per basic share.

“supporting a compelling long-term trajectory for the Company.” Financial Results for the Quarter Ended March 31, 2026 U.S. net product sales for the first quarter of 2026 were $124.5 million, compared to $75.9 million for the same period in 2025. The increase is attributable to growth in sales of FILSPARI. Research and development (R&D) expenses for the first quarter”